Next Article in Journal
Facile and Green Synthesis of Starfruit-Like ZIF-L, and Its Optimization Study
Next Article in Special Issue
Radiosynthesis of 5-[18F]Fluoro-1,2,3-triazoles through Aqueous Iodine–[18F]Fluorine Exchange Reaction
Previous Article in Journal
Benzo[f]indole-4,9-dione Derivatives Effectively Inhibit the Growth of Triple-Negative Breast Cancer
Previous Article in Special Issue
Base-Mediated Claisen Rearrangement of CF3-Containing Bisallyl Ethers
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 26
Issue 15
10.3390/molecules26154415
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

2-Aryl-6-Polyfluoroalkyl-4-Pyrones as Promising RF-Building-Blocks: Synthesis and Application for Construction of Fluorinated Azaheterocycles

by
Sergey A. Usachev
,
Diana I. Nigamatova
,
Daria K. Mysik
,
Nikita A. Naumov
,
Dmitrii L. Obydennov
and
Vyacheslav Y. Sosnovskikh
*
Institute of Natural Sciences and Mathematics, Ural Federal University, 51 Lenina Ave., 620000 Ekaterinburg, Russia
*
Author to whom correspondence should be addressed.
Molecules 2021, 26(15), 4415; https://doi.org/10.3390/molecules26154415
Submission received: 28 June 2021 / Revised: 17 July 2021 / Accepted: 19 July 2021 / Published: 21 July 2021
(This article belongs to the Special Issue Organofluorine Chemistry and Beyond)
Browse Figures
Versions Notes

Abstract

:
A convenient and general method for the direct synthesis of 2-aryl-6-(trifluoromethyl)-4-pyrones and 2-aryl-5-bromo-6-(trifluoromethyl)-4-pyrones has been developed on the basis of one-pot oxidative cyclization of (E)-6-aryl-1,1,1-trifluorohex-5-ene-2,4-diones via a bromination/dehydrobromination approach. This strategy was also applied for the preparation of 2-phenyl-6-polyfluoroalkyl-4-pyrones and their 5-bromo derivatives. Conditions of chemoselective enediones bromination were found and the key intermediates of the cyclization of bromo-derivatives to 4-pyrones were characterized. Synthetic application of the prepared 4-pyrones has been demonstrated for the construction of biologically important CF3-bearing azaheterocycles, such as pyrazoles, pyridones, and triazoles.

Graphical Abstract

1. Introduction

4-Pyrone unit is an important heterocyclic motif, which is frequently present in numerous natural products that exhibit a wide range of important biological activities [1,2,3,4,5] and medicines, such as phenoxan [5] (Figure 1). Mainly, pyrones are of interest as useful and versatile building-blocks for the synthesis of valuable molecules [6,7,8,9], including pharmaceuticals [10] and pyranic fluorophores [11]. Pyrones as polyelectrophilic substrates and cyclic enone are able to react regioselectively with nucleophiles to undergo ring-opening transformations affording azaheterocycles [12,13,14,15,16]. The formation of the product is usually very sensitive to the reaction conditions (acidity, solvent polarity, temperature) that allows divergent syntheses on the basis of 4-pyrones [15,16].
It is known that fluorine-bearing compounds are of considerable interest for medicinal chemistry and agrochemistry [17]. The search for readily available and highly functionalized fluorinated building blocks for the construction of complex molecules is an important task for the synthesis of new bioactive substances.
To date considerable attention has been focused on 4-pyrones bearing the electron-withdrawing RF group, which demonstrate higher reactivity with high chemoselectivity of processes compared to non-fluorinated analogs [17,18]. The ring-opening reactions of 2-RF-4-pyrones can be applied for the preparation of a wide range of trifluoromethylated azaheterocycles, such as indoles, regioisomeric pyrazoles, pyridines, benzodiazepines etc., [14,16,17,18].
Despite the promising synthetic utility of CF3-bearing 4-pyrones, they remain to be hard-to-reach compounds [17,18]. The methods for the construction of 4-pyrones are actively developed, and in the literature there are three general approaches for the synthesis of 2-RF-4-pyrones based on (i) cyclization of tricarbonyl compounds or their derivatives prepared via Claisen condensation [19,20,21,22], (ii) cycloadditions of ketenes [23,24,25], and (iii) modification of substituted 2-RF-4-pyrones (usually for carboxylic acid derivatives) via side-chain transformations [26] (Scheme 1). However, there are usually some limitations connected with the narrow scope of obtained pyrones, variation of the nature of the substituents in several positions of the pyrone ring, and preparation of 4-pyrones bearing long-chain polyfluoroakyl substituents.
Inspired by the chemistry of 2-CF3-chromones (benzopyrones) [27] and 2-CF3-4-pyrones [18], we decided to find an approach for the construction of a range of novel arylated 2-RF-4-pyrones as useful building-blocks for the preparation of fluorinated heterocycles. The number of 2-aryl-6-(trifluoromethyl)-4-pyrones described in the literature is limited by several examples [23,24,25], and there is also the publication regarding the reaction of 2-phenyl-6-(trifluoromethyl)-4-pyrone and salicylic aldehyde with no mention of its synthesis [28]. Thus, there is no general method for the synthesis of the fluorinated 2-aryl-4-pyrones at the moment.
Recently, methods for the preparation of pyrones based on the cyclization of acetylenyl-1,3-diketones have been actively developed [29,30,31,32,33], which allows the switchable preparation of 4-pyrones or furanones. Similar approach is the use of dibromo derivatives, which can react as synthetic equivalents of acetylenyl-1,3-diketones and undergo dehydrobromination reactions under basic conditions [34,35,36,37]. This method was applied for the preparation of 2-aryl-4-pyrones bearing the methyl and carboethoxy substituents. However, low selectivity of the bromination reaction of the starting enediones, difficult isolation of intermediate products, low yields, and very high sensitivity to the nature of the substituents strongly restrict its utilization.
The chemical properties of 6-aryl-1,1,1-trifluorohex-5-ene-2,4-diones remain unexplored, but they can be considered as a platform for the preparation of new fluorinated compounds [38,39,40,41]. The presence of several functional groups (conjugated double bonds and the diketone moiety) in their molecules makes them attractive and useful tools in organic synthesis. The introduction of the strong electron-withdrawing trifluoromethyl group can lead to a change in the chemoselectivity of the bromination reaction of 6-aryl-1,1,1-trifluorohex-5-ene-2,4-diones in comparison with non-fluorinated analogs and to changes in the cyclization step due to the ability of this group to stabilize cyclic and hemiacetal forms [17].
In the present work, we have developed a general method for the preparation of 2-aryl-6-polyfluoroalkyl-4-pyrones and their 3-bromo derivatives based on one-pot cyclization through the stage of bromination/dehydrobromination of enediones. The synthetic potential of the pyrones was demonstrated on the example of regioselective reactions with N-nucleophiles.

2. Results and Discussion

We started our research with the preparation of fluorinated enediones 2 based on the condensation reaction of 4-aryl-3-buten-2-ones 1 with ethyl polyfluoroalkanoates in the presence of sodium hydride in diethyl ether at room temperature or lithium hydride in benzene under reflux (Scheme 2, Table 1). Both methods were comparably effective, and CF3-bearing products 2a–i were obtained in 51–92% yields. Compounds 2a,f–h have been described in the literature, but they were prepared by other methods [38,39,40,41]. Besides, this approach was applied for the preparation of polyfluorinated enediones 2j–l in 43–51%.
We first focused on the bromination of CF3-containing compounds 2a–i in order to obtain active intermediates and to develop a general method for the construction of pyrones based on enediones 2. Both the double bond and the diketone moiety in 6-aryl-1,1,1-trifluorohex-5-ene-2,4-diones 2 can undergo an electrophilic attack of bromine. To estimate the influence of conditions on conversion, the chemo- and stereoselectivity (see detailed data in Supplementary Materials), the bromination reaction was examined for compound 2b bearing the para-fluorophenyl substituent (Scheme 3, Table 2). It was shown that the most active fragment is the double bond that leads to the initial formation of dibromo derivative 3b, and no product of initial attack only at the methylene group of the diketone moiety was found. At the same time, compounds 3 due to the absence of conjugation were able to react with Br2 by the diketone moiety at a comparable rate with the starting enediones 2 giving tribromo derivatives 4.
When 1 equiv. of bromine was used, incomplete conversion was usually observed, accompanied by the formation of tribromo derivative 4b. Bromination in acetic acid gave low conversion (26%) and predominant formation of the tribromo derivative (3b:4b = 9:17) (entry 1). Carrying out the reaction in aprotic polar solvents CH2Cl2 and t-BuOMe made it possible to increase the conversion to 58 and 83%, respectively, but the selectivity turned out to be low (entries 2,4). The use of non-polar aprotic solvents (dioxane, CS2) led to the improved 3b:4b ratio and 71–75% conversion (entries 5,6). When the reaction was carried out in benzene, the highest conversion (88%), the highest NMR yield of 3b, and the good selectivity of the reaction were found (3b:4b = 78:10) (entry 7). A slight increase in the amount of bromine (up to 1.2 equiv.) led to a decrease in selectivity (3b:4b = 79:21), although the starting compound 2b was not detected at all (entry 8).
Further investigation showed that the bromination reaction is very sensitive to the nature of the substituents in the aromatic ring (Scheme 3, Table 2, and Table S1 in Supplementary Materials). Thus, the reaction proceeded with the highest selectivity with one equivalent of bromine in benzene for compounds bearing moderate and good π-donors (4-MeO, 4-F or Ar = 2-Th) (entries 7,10,11). The introduction of electron-withdrawing substituents (4-Cl, 3-NO2) into the aromatic ring decreased the selectivity of the transformation for compounds 2c,e due to incomplete conversion and the formation of tribromo derivatives 4 as major products (entries 12,13). Even in the case of enedione 2a (Ar = Ph), selectivity and conversion of bromination in benzene turned out to be poor (entry 14), however, the use of CH2Cl2 as a solvent improved the selectivity and the conversion (entry 15). The introduction of the strong electron-donating substituent (4-Me2N) led to preferential bromination at the aromatic ring rather than at the double bond followed by cyclization because of basic properties of the substituent (Scheme S1 in Supplementary Materials). It should be noted that, in all cases, compounds 3 were formed as a sole anti-dibromo diastereoisomer according to the classical concept of electrophilic addition of bromine to alkenes via the cyclic bromonium cation [42].
Further, we decided to develop a procedure for the bromination of both fragments of enediones 2 simultaneously for the selective preparation of tribromo derivatives 4. The reaction of enedione 2b with an excess of bromine (2.2 equiv.) in benzene gave products with low selectivity (3b:4b = 56:44) (Table 2, entry 9). Moreover, significant amounts of corresponding dihydropyrones were formed as a result of spontaneous acid-catalyzed cyclization. One of the highest yields of compound 4b in reaction with 1 equiv. of bromine was observed in dichloromethane (entry 2). The use of bromine (2.5 equiv.) in this solvent led to the almost selective formation of tribromo derivative 4b as a mixture of two diastereoisomers in a ratio of 80:20 (entry 3).
Although the reaction of enediones 2 with Br2 gave dibromo derivatives 3 or tribromo derivatives 4 as major products, we did not usually isolate them in pure form to avoid additional losses because of their ability to cyclize and high reactivity. But for several cases, these compounds were obtained as a single isomer by recrystallization. The reaction of enediones 2a,g with one equivalent of bromine in acetic acid made it possible to obtain dibromo derivatives 3a and 3g in 71 and 28% yields, respectively (Scheme 4).
The reaction of chloro-substituted enedione 2c with an excess of bromine (2.5 equiv.) in CH2Cl2 led to tribromo derivative 4c (dr = 80:20) smoothly in 82% yield. Compound 4c in pure crystalline form prepared by recrystallization from hexane is stable and can be stored for a long time without changes.
The structure of tribromo derivatives 4 was established on the basis of elemental analysis data and 1H and 19F NMR spectra (Table S3 in Supplementary Materials). In the 1H NMR spectra of these compounds in CDCl3, two singlets of the diastereotopic OH groups were observed at δ 4.06–4.46 and 4.62–4.79 ppm. The 19F NMR spectra exhibit the CF3 group at δ 79.7–79.9 ppm indicating its location at the saturated carbon atom. For compounds 2 and 3, the characteristic chemical shifts of the trifluoromethyl group appeared at δ 84.5–85.0 and 86.0 ppm, respectively (Table S2 in Supplementary Materials).
At the next stage of our work, we studied the cyclization of dibromo derivatives 3a,g in the presence of bases. The use of t-BuOK in THF or pyridine, DIPEA, DBU, NaHCO3 in various solvents (acetone, ethanol, DMSO) at room temperature did not allow us to obtain 4-pyrone 5a in an acceptable yield. The most favorable conditions turned out to be stirring with a 2.5-fold excess of triethylamine in acetone for three days (Scheme 5). In addition, the isolation of the product, in this case, does not require chromatography, and pyrones 5a,g precipitated in pure form upon dilution with water in 51–54% yields. This approach can be scaled up to 5 g of enedione 2a, and the yield of pyrone 5a was 36% in two stages.
The cyclization mechanism of compounds 3 includes the formation of dihydropyran intermediate B via two possible pathways. The first path comprises the elimination of hydrogen bromide (E) and the production of bromoenone A, which then undergoes an intramolecular Michael reaction (1,4-AN). The second possibility is the direct intramolecular nucleophilic substitution of bromine (SN). As mentioned above, the cyclic pyranic form B was observed in the bromination reaction mixtures (Table 2), whereas bromoenones A were detected by NMR spectroscopy on the treatment of the dibromo derivatives 3 with pyridine at room temperature. The easy formation of 2-bromoenones from 2,3-dibromoketones is also well presented in the literature [42]. Thus, it can be assumed that the first path is more preferable in basic conditions. Intermediate A′ was isolated in pure form with the use of column chromatography (56% yield) from enedione 2i via bromination (1 equiv.) and subsequent monodehydrobromination by DIPEA at room temperature.
Tribromo derivatives 4 undergo cyclization under the action of triethylamine in acetone at room temperature much slower, furthermore, the high basicity of the medium could provide a possibility of side reactions associated with detrifluoroacetylation [41]. Therefore, dehydrohalogenation of 4 was carried out by refluxing for 10 h in pyridine as a solvent and a weaker base (Scheme 6). The cyclization of compound 4c gave pyrone 6c in 36% yield. These results demonstrate that the cyclization step determines mainly total output of the pyrones. Moreover, the difference in reaction rates of cyclization of tribromo derivatives 4 and dibromo derivatives 3 allowed the isolation of pyrones 5 in the presence of Et3N in acetone selectively, even when the reaction mixtures of the brominated intermediates were used.
With the optimized conditions of the bromination and cyclization of intermediate bromo derivatives in hand, we decided to develop a simple one-pot two-step preparative method for the synthesis of 4-pyrones 5 and 6 based on oxidative cyclization of enediones 2. Considering that the reaction mixtures of bromination contain various bromine-bearing forms (cyclic and acyclic), the overall efficiency and convenience of this two-step process without intermediate purification can improve (Scheme 7, Table 3).
For the preparation of 4-pyrones 5 in the one-pot approach, enediones 2 were treated with 1 equiv. of bromine in benzene (Method A) for compounds bearing electron-donating substituents (F, Me, MeO) and in CH2Cl2 (Method B) for compounds bearing weak electron-withdrawing substituents (Cl, Br) or H at the C-4 position. After bromination, the solvent was evaporated, and the cyclization was carried out using Et3N (2.5 equiv.) in acetone, as a result, pyrones 5 were obtained in 28–69% yields.
The preparation of 3-bromo-4-pyrones 6 with a one-pot method was possible only for substrates bearing weak electron-donating (H, 4-Me, 4-F) and electron-withdrawing groups (4-Cl, 3-NO2) in the benzene ring since aromatic bromination was unavoidable with an excess of bromine in case of highly activated aryl substituents. At the first stage, enedione 2 was treated with 2.5 equiv. of bromine in CH2Cl2 and subsequent heating at 100 °C in pyridine for 10 h led to the formation of pyrones 6 in 4–42% yields (Method C).
This one-pot approach was also applied for the preparation of phenyl-4-pyrones bearing various polyfluoroalkyl substituent. No significant difference in reactivity was observed depending on fluorine content or chain length of RF-moiety, and the cyclization of enediones 2j–l in the presence of 1 equiv. of bromine (Method B) gave 4-pyrones 5j–l in 40–70% yields (Scheme 8). The use of Method C led to 3-bromopyrones 6j–l in 24–33% yields.
The structure of 4-pyrones 5 and 6 was established on the basis of elemental analysis data, HRMS and NMR spectra. In the 1H NMR spectra of compounds 5 in CDCl3, characteristic doublets of H-3 and H-5 protons of the pyrone ring were observed at δ 6.63–6.88 ppm with a coupling constant of 1.8–2.2 Hz. In the case of pyrones 6, the signal of the H-5 proton of the pyrone ring appeared as a singlet at δ 6.88–7.04 ppm (CDCl3).
The next step was to study the chemical properties of 2-aryl-6-(trifluoromethyl)-4-pyrones with N-nucleophiles to obtain azaheterocycles (Scheme 9). The reaction of pyrone 5a with ammonia in ethanol in an autoclave at 120 °C for 10 h led to the formation of pyridone 7 in 70% yield. The ring-opening transformation of pyrone 5a with sodium azide [43] in DMSO afforded triazole 8 in 55% yield. Phenylhydrazine reacted with pyrone 5a regioselectively attacking with the amino group at the C-2 and C-4 positions to give pyrazole 9. The structure of pyrazole 9 was assigned based on NMR spectra according to the literature data [16,34].
Thus, a convenient and general method for the synthesis of 2-aryl-6-polyfluoroalkyl-4-pyrones and their bromo derivatives has been developed based on one-pot oxidative cyclization of fluorinated enediones. The selectivity of monobromination of 6-aryl-1,1,1-trifluorohex-5-ene-2,4-diones is connected with the predominant electrophilic attack on the double bond and strongly depends on the solvent used and the nature of the substituent in the aromatic ring, which determines the scope of obtained fluorinated 2-aryl-4-pyrones. 6-Aryl-1,1,1-trifluorohex-5-ene-2,4-diones bearing electron-withdrawing and weak electron-donating substituents in the aromatic ring react with an excess of bromine leading to tribromo derivatives as a result of bromination of the double bond and the diketone moiety. Di- and tribromo derivatives in a basic medium selectively undergo cyclization to form 4-pyrones. The resulting 4-pyrones have proven to be useful building blocks and have been utilized to synthesize CF3-bearing heterocycles, which are of further interest in terms of potential biological activity.

3. Materials and Methods

NMR spectra were recorded on Bruker DRX-400 (1H: 400 MHz, 13C: 100 MHz, 19F: 376.5 MHz) and Bruker Avance III-500 (1H: 500 MHz, 13C: 126 MHz, 19F: 471 MHz) spectrometers in DMSO-d6 and CDCl3. The chemical shifts (δ) are reported in ppm relative to the internal standard TMS (1H NMR), C6F6 (19F NMR), and residual signals of the solvents (13C NMR). IR spectra were recorded on a Shimadzu IRSpirit-T spectrometer using an attenuated total reflectance (ATR) unit (FTIR mode, ZnSe crystal), the absorbance maxima (ν) are reported in cm–1. Elemental analyses were performed on an automatic analyzer PerkinElmer PE 2400. Melting points were determined using a Stuart SMP40 melting point apparatus. Column chromatography was performed on silica gel (Merck 60, 70–230 mesh). All solvents that were used were dried and distilled by standard procedures. Arylideneacetones 1 have been synthesized according to the procedure, previously described in the literature [44].

3.1. Synthesis of Enediones 2a–l

General Procedure. A suspension of NaH (60% by weight in mineral oil) (240 mg, 6.0 mmol) in dry Et2O (5 mL) was cooled on an ice bath, then CF3CO2Et (0.86 g, 6.0 mmol) and a solution of arylideneacetone 1 (4.0 mmol) in dry Et2O (3 mL) were successively added under stirring. The reaction mixture was warmed to room temperature and stirred for 20 h. Then 1M aqueous HCl (10 mL) was added, and the organic phase was separated (if the precipitate of diketonate formed, it was filtered and treated with 1M aqueous HCl (10 mL)). The aqueous phase was extracted with AcOEt (5 mL). The combined organics were washed with H2O and dried over anhydrous Na2SO4, the solvents evaporated, and the residue recrystallized from hexane with decantation of hot solution from insoluble tarry by-products.
General procedure (with LiH) [38]. A solution of arylideneacetone 1 (4.0 mmol) in dry C6H6 (1 mL) and CF3CO2Et (0.86 g, 6.0 mmol) were successively added to a suspension of LiH (48 mg, 6.0 mmol) in dry C6H6 (4 mL) under stirring. The reaction mixture was warmed until the reaction started and then was stirred at room temperature for 20 h. After that, the reaction mixture was poured into a mixture of ice (4 g) and H2SO4 (1 mL), extracted with chloroform (5 mL), and dried over MgSO4. The solvents were evaporated, and the residue recrystallized from hexane with decantation of hot solution from insoluble tarry by-products.
(E)-1,1,1-Trifluoro-6-phenylhex-5-ene-2,4-dione (2a). Yield 0.73 g (75%), colorless needles, mp 56–58 °C (lit. mp 58 °C [40], 61–61.5 °C [38]).1H NMR (400 MHz, CDCl3) enol form: δ 6.04 (1H, s, 3-CH); 6.58 (1H, d, J = 15.9 Hz, 5-CH); 7.37–7.57 (3H, m, H Ph); 7.53–7.61 (2H, m, H-2, H-6 Ph); 7.77 (1H, d, J = 15.9 Hz, 6-CH); 14.22 (1H, s, OH). The analytical data are in consistence with the literature [38,40].
(E)-1,1,1-Trifluoro-6-(4-fluorophenyl)hex-5-ene-2,4-dione (2b). Yield 0.67 g (64%), yellow prisms, mp 83–84 °C. IR (ATR) ν 1637, 1578, 1509, 1444, 1414. 1H NMR (500 MHz, CDCl3) enol form: δ 6.02 (1H, s, 3-CH); 6.50 (1H, d, J = 15.8 Hz, 5-CH); 7.12 (2H, t, J = 8.6 Hz, JHF = 8.6 Hz, H-3, H-5 Ar); 7.57 (2H, dd, J = 8.7 Hz, J = 5.3 Hz, H-2, H-6 Ar); 7.73 (1H, d, J = 15.8 Hz, 6-CH); 14.24 (1H, s, OH). 19F NMR (376 MHz, CDCl3) δ 53.9 (tt, JHF = 8.4 Hz, JHF = 5.4 Hz, F); 84.7 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 95.6 (q, 3JCF = 1.4 Hz, C-3); 116.4 (d, 2JCF = 22.0 Hz, C-3, C-5 Ar); 116.7 (q, 1JCF = 286.6 Hz, CF3); 120.8 (d, 6JCF = 2.4 Hz, C-5); 130.4 (s, C-1 Ar); 130.5 (d, 4JCF = 8.8 Hz, C-2, C-6 Ar); 142.3 (C-6); 164.3 (d, 1JCF = 253.2 Hz, C-4 Ar); 180.5 (q, 2JCF = 36.1 Hz, C-2); 180.8 (C-4). HRMS (ESI) m/z [M + H]+. Calcd for C12H9F4O2: 261.0539. Found: 261.0533.
(E)-6-(4-Chlorophenyl)-1,1,1-trifluorohex-5-ene-2,4-dione (2c). Yield 0.66 g (60%), yellow needles, mp 92–93 °C. IR (ATR) ν 3072, 3035, 1632, 1610, 1573, 1561, 1491, 1454, 1410. 1H NMR (500 MHz, CDCl3) enol form: δ 6.03 (1H, s, 3-CH); 6.54 (1H, d, J = 15.8 Hz, 5-CH); 7.40 (2H, d, J = 8.5 Hz, H Ar); 7.50 (2H, d, J = 8.5 Hz, H Ar); 7.71 (1H, d, J = 15.8 Hz, 6-CH); 14.17 (1H, s, OH). 19F NMR (471 MHz, CDCl3) δ 84.6 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 95.80 (q, 3JCF = 1.4 Hz, C-3); 116.63 (q, 1JCF = 285.6 Hz, CF3); 121.5 (s, C-5); 129.4 (s, 2H); 129.6 (s, 2H); 132.7 (s, C Ar); 137.1 (s, C Ar); 142.1 (s, C-6); 180.4 (s, C-4); 180.8 (q, 2JCF = 36.1 Hz, C-2). Anal. Calcd for C12H8ClF3O2: C 52.10; H 2.91. Found: C 51.93; H 2.94%.
(E)-6-(4-Bromophenyl)-1,1,1-trifluorohex-5-ene-2,4-dione (2d). Yield 1.18 g (92%), white crystals, mp 86–87 °C. IR (ATR) ν 1632, 1609, 1582, 1487, 1454, 1406. 1H NMR (400 MHz, CDCl3) enol form: δ 6.03 (1H, s, 3-CH); 6.56 (1H, d, 3J = 15.9 Hz, 5-CH); 7.43 (2H, d, 3J = 8.4 Hz, H Ar); 7.56 (2H, d, 3J = 8.4 Hz, H Ar); 7.69 (1H, d, 3J = 15.9 Hz, 6-CH); 14.15 (1H, s, OH). 19F NMR (376 MHz, CDCl3) δ 84.7 (s, CF3). 13C NMR (101 MHz, CDCl3) δ 95.8 (unresolved q, C-3); 116.7 (q, 1JCF = 285.5 Hz, CF3); 121.6 (C-5); 125.5 (C Ar); 129.8 (2C Ar); 132.4 (2C Ar); 133.1 (C Ar); 142.1 (C-6); 180.4 (C-4); 180.8 (q, 2JCF = 36.2 Hz, C-2). Anal. Calcd for C12H8BrF3O2: C 44.89; H 2.51. Found: C 45.03; H 2.57%.
(E)-1,1,1-Trifluoro-6-(3-nitrophenyl)hex-5-ene-2,4-dione (2e). Yield 0.59 g (51%), white scales, mp 118–119 °C. IR (ATR) ν 1644, 1610, 1577, 1523, 1477, 1429. 1H NMR (400 MHz, CDCl3) enol form: δ 6.10 (1H, s, 3-CH); 6.70 (1H, d, 3J = 15.9 Hz, 5-CH); 7.63 (1H, t, 3J = 8.0 Hz, H-5 Ar); 7.79 (1H, d, 3J = 15.9 Hz, 6-CH); 7.86 (1H, dt, 3J = 7.7 Hz, 4J = 1.0 Hz, H-6 Ar); 8.27 (1H, ddd, 3J = 8.5 Hz, 4J = 2.1 Hz, 4J = 0.8 Hz, H-4 Ar); 8.44 (1H, t, 4J = 1.8 Hz, H-2 Ar); 13.96 (1H, s, OH). 19F NMR (376 MHz, CDCl3) δ 84.5 (s, CF3). HRMS (ESI) m/z [M – H]–. Calcd for C12H7F3NO4: 286.0327. Found: 286.0331.
(E)-1,1,1-Trifluoro-6-(p-tolyl)hex-5-ene-2,4-dione (2f). Yield 0.67 g (65%), yellow needles, mp 61–62 °C. IR (ATR) ν 3031, 2956, 2926, 2360, 1652, 1594, 1575, 1516, 1447, 1416. 1H NMR (400 MHz, CDCl3) enol form: δ 2.40 (3H, s, Me); 6.01 (1H, s, 3-CH); 6.53 (1H, d, J = 15.8 Hz, 5-CH); 7.23 (2H, d, J = 8.0 Hz, H-3, H-5 Ar); 7.47 (2H, d, J = 8.1 Hz, H-2, H-6 Ar); 7.75 (1H, d, J = 15.8 Hz, 6-CH); 14.30 (1H, s, OH). 19F NMR (376 MHz, CDCl3) δ 84.7 (s, CF3). 13C NMR (101 MHz, CDCl3) δ 21.6 (CH3); 95.4 (q, 3JCF = 1.5 Hz, C-3); 116.8 (q, 1JCF = 285.3 Hz, CF3); 120.0 (C-5); 128.6 (2C Ar); 129.9 (2C Ar); 131.5 (C Ar); 141.9 (C Ar); 143.90 (C-6); 180.1 (q, 2JCF = 36.0 Hz, C-2); 181.5 (C-4). Anal. Calcd for C13H11F3O2: C 60.94; H 4.33. Found: C 60.96; H 4.47%. The analytical data are in consistence with the literature [41].
(E)-1,1,1-Trifluoro-6-(4-methoxyphenyl)hex-5-ene-2,4-dione (2g). Yield 0.88 g (81%), yellow needles, mp 100–101 °C (lit. mp 98 °C [40]). IR (ATR) ν 1633, 1568, 1511, 1453, 1441, 1420. 1H NMR (500 MHz, CDCl3) enol form: δ 3.86 (3H, s, OMe); 6.00 (1H, s, 3-CH); 6.45 (1H, d, 3J = 15.8 Hz, 5-CH); 6.94 (2H, d, 3J = 8.8 Hz, H-3, H-5 Ar); 7.53 (2H, d, 3J = 8.4 Hz, H-2, H-6 Ar); 7.74 (1H, d, 3J = 15.8 Hz, 6-CH); 14.45 (1H, s, OH). 19F NMR (471 MHz, CDCl3) δ 84.8 (s, CF3). 13C NMR (101 MHz, CDCl3) δ 55.5 (OMe); 95.2 (q, 2JCF = 1.2 Hz, C-3); 114.7 (2C Ar); 116.9 (q, 1JCF = 285.1 Hz, CF3); 118.6 (C-5); 126.9 (C Ar); 130.5 (2C Ar); 143.7 (C-6); 162.2 (C Ar); 179.7 (q, 2JCF = 35.9 Hz, C-2); 181.9 (C-4). Anal. Calcd for C13H11F3O3: C 57.36; H 4.07. Found: C 57.38; H 4.20%. The analytical data are in consistence with the literature [40].
(E)-6-(4-(Dimethylamino)phenyl)-1,1,1-trifluorohex-5-ene-2,4-dione (2h). Yield 0.76 g (67%), magenta needles, mp 79–80 °C (lit. mp 78–79 °C [39]). IR (ATR) ν 2900, 1556, 1519, 1453, 1430, 1360, 1328. 1H NMR (500 MHz, CDCl3) enol form: δ 3.07 (6H, s, NMe2); 5.95 (1H, s, 3-CH); 6.35 (1H, d, 3J = 15.6 Hz, 5-CH); 6.68 (2H, d, 3J = 8.9 Hz, H-3, H-5 Ar); 7.47 (2H, d, 3J = 8.9 Hz, H-2, H-6 Ar); 7.74 (1H, d, 3J = 15.6 Hz, 6-CH); 14.69 (1H, s, OH). 19F NMR (471 MHz, CDCl3) δ 85.0 (s, CF3). Anal. Calcd for C14H14F3NO2: C 58.95; H 4.95; N 4.91. Found: C 58.92; H 4.94; N 4.79%. The analytical data are in consistence with the literature [39].
(E)-1,1,1-Trifluoro-6-(thiophen-2-yl)hex-5-ene-2,4-dione (2i). Yield 0.83 g (84%), yellow rectangular prisms, mp 94–95 °C. IR (ATR) ν 1577, 1503, 1437, 1416. 1H NMR (400 MHz, CDCl3) enol form: δ 5.99 (1H, s, 3-CH); 6.36 (1H, d, 3J = 15.5 Hz, 5-CH); 7.11 (1H, dd, 3J = 4.9 Hz, 3J = 3.8 Hz, H-4 Th); 7.35 (1H, d, 3J = 3.5 Hz, H-3 Th); 7.48 (1H, d, 3J = 5.0 Hz, H-5 Th); 7.88 (1H, d, 3J = 15.5 Hz, 6-CH); 14.28 (1H, s, OH). 19F NMR (376 MHz, CDCl3) δ 84.8 (s, CF3). 13C NMR (101 MHz, CDCl3) δ 95.5 (unresolved q, C-3); 116.8 (q, 1JCF = 285.3 Hz, CF3); 119.8 (C-5); 128.6; 130.2; 132.4; 136.2; 139.8; 180.1 (q, 2JCF = 36.0 Hz, C-2); 180.8 (C-4). Anal. Calcd for C10H7F3O2S: C 48.39; H 2.84. Found: C 48.36; H 2.75%.
(E)-1,1-Difluoro-6-phenylhex-5-ene-2,4-dione (2j). Yield 0.39 g (43%), yellow crystals, mp 85–87 °C. IR (ATR) ν 3030, 1647, 1495, 1341, 1180, 1105, 867, 757. 1H NMR (500 MHz, CDCl3) enol form: δ 5.91 (1H, t, 2JHF = 54.3 Hz, CF2H); 6.04 (1H, s, 3-CH); 6.58 (1H, d, J = 15.9 Hz, 5-CH); 7.39–7.44 (3H, m, H Ph); 7.51–7.62 (2H, m, H-2, H-6 Ph); 7.72 (1H, d, J = 15.9 Hz, 6-CH); 14.58 (1H, s, OH). 19F NMR (471 MHz, CDCl3) δ 35.0 (dd, 2JHF = 54.4 Hz, 4JHF = 0.5 Hz, CF2H). 13C NMR (126 MHz, CDCl3) δ 96.0 (t, 3JCF = 1.9 Hz, C-4); 109.6 (t, 1JCF = 249.0 Hz, CF2H); 121.8 (C-6); 128.4 (2C Ph); 129.1 (2C Ph); 130.8 (C Ph); 134.4 (C Ph); 142.7 (C-7); 181.0 (C-5); 186.5 (t, 2JCF = 25.7 Hz, C-3). Anal. Calcd for C12H10F2O2: C 64.29; H 4.50. Found: C 64.69; H 4.35.
(E)-6,6,7,7-Tetrafluoro-1-phenylhept-1-ene-3,5-dione (2k). Yield 0.47 g (43%), yellow liquid. IR (ATR) ν 3028, 1633, 1580, 1449, 1244, 1110, 700. 1H NMR (400 MHz, CDCl3) enol form: δ 6.10 (tt, 2JHF = 52.9 Hz, 3JHF = 5.1 Hz, CF2H); 6.13 (1H, s, 4-CH); 6.58 (1H, d, J = 15.9 Hz, 6-CH); 7.40–7.45 (3H, m, H Ph); 7.53–7.61 (2H, m, H-2, H-6 Ph); 7.77 (1H, d, J = 15.9 Hz, 7-CH); 14.45 (1H, s, OH). 19F NMR (376 MHz, CDCl3) δ 23.4 (dt, 2JHF = 52.9 Hz, 3JFF = 6.9 Hz, CF2H); 35.8 (tdd, 3JFF = 6.9 Hz, 3JHF = 5.1 Hz, 4JHF = 0.8 Hz, CF2). 13C NMR (126 MHz, CDCl3) δ 96.8 (unresolved t, C-4); 109.1 (tt, 1JCF = 251.2 Hz, 2JCF = 34.1 Hz, CF2H); 109.5 (tt, 1JCF = 258.5 Hz, 2JCF = 27.8 Hz, CF2); 121.3 (C-6); 128.4 (2C Ph); 129.1 (2C Ph); 131.0 (C Ph); 134.3 (C Ph); 143.6 (C-7); 180.1 (q, 2JCF = 26.7 Hz, C-3); 180.9 (C-5). HRMS (ESI) m/z [M + H]+. Calcd for C13H11F4O2: 275.0695. Found: 275.0694.
(E)-6,6,7,7,8,8,9,9-Octafluoro-1-phenylnon-1-ene-3,5-dione (2l). Yield 0.76 g (51%), yellow liquid. IR (ATR) ν 2929, 1633, 1580, 1450, 1172, 1034, 972, 787. 1H NMR (500 MHz, CDCl3) δ enol form (88%): 6.08 (1H, s, 4-CH); 6.12 (1H, tt, 2JHF = 52.0 Hz, 3JHF = 5.5 Hz, CF2H); 6.58 (1H, d, J = 15.8 Hz, 2-CH); 7.39–7.47 (3H, m, H Ph); 7.54–7.61 (2H, m, H-2, H-6 Ph); 7.79 (1H, d, J = 15.8 Hz, 1-CH); 14.33 (1H, s, OH); keto form (12%): 2.77 (2H, s, CH2); 6.08 (1H, tt, 2JHF = 52.0 Hz, 3JHF = 5.5 Hz, CF2H); 6.46 (1H, d, J = 15.9 Hz, 2-CH); 7.39–7.47 (3H, m, H Ph); 7.54–7.61 (2H, m, H-2, H-6 Ph); 7.81 (1H, d, J = 15.9 Hz, 1-CH). 19F NMR (471 MHz, CDCl3) δ enol form (88%): 24.4 (dm, 2JHF = 51.9 Hz, CF2H); 32.0 –32.1 (m, 8-CF2); 37.0 (t, 3JFF = 8.2 Hz, 7-CF2); 40.5 (t, 3JFF = 9.9 Hz, 6-CF2); keto form (12%): 24.4 (dm, 2JHF = 51.9 Hz, CF2H); 31.9–32.0 (m, 8-CF2); 36.9 (t, 3JFF = 8.2 Hz, 7-CF2); 42.3 (t, 3JFF = 9.6 Hz, 6-CF2). 13C NMR (126 MHz, CDCl3) δ 97.2 (unresolved m, C-6); 107.6 (tt, 1JCF = 254.7 Hz, 2JCF = 30.9 Hz, CF2H); 107.7–113.5 (m, 3CF2); 121.0 (C-8); 128.5 (2C Ph); 129.1 (2C Ph); 131.2 (C Ph); 134.2 (C Ph); 144.0 (C-9); 180.5 (C-7); 182.5 (t, 2JCF = 26.7 Hz, C-5). HRMS (ESI) m/z [M + H]+. Calcd for C15H11F8O2: 375.0631. Found: 375.0627.

3.2. Synthesis of Compounds 3a,g

General procedure. A solution of Br2 (3.20 g, 0.020 mol) in glacial AcOH (5.7 mL) was added dropwise to enedione 2 (0.020 mol) in glacial AcOH (18 mL) cooled by a water bath. After that, the reaction mixture was stirred for 1 h at room temperature. The resulting solution was diluted by water (30 mL). The precipitate that formed was filtered. If it is needed, the pure product can be obtained by recrystallization from heptane.
(5S,6R)-5,6-Dibromo-1,1,1-trifluoro-6-phenylhexane-2,4-dione (3a). Yield 5.71 g (71%), beige powder, mp 119–120 °C. IR (ATR) ν 1665, 1629, 1604, 1497, 1458, 1434. 1H NMR (400 MHz, DMSO-d6) enol form: δ 5.56 (1H, d, 3J = 11.7 Hz, CHBr); 6.08 (1H, d, 3J = 11.7 Hz, CHBr); 6.30 (1H, s, 3-CH); 7.29–7.46 (3H, m, H Ph); 7.49–7.54 (2H, m, H-2, H-6 Ph). 1H NMR (400 MHz, CDCl3) δ 4.96 (1H, d, 3J = 11.6 Hz, CHBr); 5.39 (1H, d, 3J = 11.6 Hz, CHBr); 6.24 (1H, s, 3-CH); 7.38–7.50 (5H, m, H Ph). 19F NMR (471 MHz, CDCl3) δ 86.0 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 48.8; 51.2; 96.5; 117.1 (q, J = 280.4 Hz, CF3); 128.0; 129.0; 129.6; 137.4; 171.9 (q, J = 37.2 Hz, C-2); 190.6. HRMS (ESI) m/z [M – H]–. Calcd for C12H8Br2F3O2: 398.8843. Found: 398.8835.
(5S,6R)-5,6-Dibromo-1,1,1-trifluoro-6-(4-methoxyphenyl)hexane-2,4-dione (3g). Yield 2.42 g (28%), yellow powder, mp 124–125 °C. IR (ATR) ν 1665, 1607, 1514, 1462, 1443. 1H NMR (500 MHz, CDCl3) enol form: δ 3.84 (3H, s, OMe); 4.93 (1H, d, 3J = 11.6 Hz, CHBr); 5.37 (1H, d, 3J = 11.6 Hz, CHBr); 6.21 (1H, s, 3-CH); 6.92 (2H, d, 3J = 8.6 Hz, H-3, H-5 Ar); 7.35 (2H, d, 3J = 8.6 Hz, H-2, H-6 Ar); 13.50 (1H, s, OH). 19F NMR (376 MHz, CDCl3) δ 86.0 (s, CF3). Anal. Calcd for C13H11Br2F3O3: C 36.14; H 2.57. Found: C 36.48; H 2.73%.

3.3. Synthesis of Compound 4c

A solution of Br2 (400 mg, 2.5 mmol) in CH2Cl2 (2 mL) was added to enedione 2c (277 mg, 1 mmol) in CH2Cl2 (8 mL) under cooling on an ice-bath. The reaction mixture was left at room temperature for 15 h, and then the solvent was evaporated without heating. The residue is a mixture of diastereoisomeres (dr = 80:20), which was recrystallized from hexane to obtain single isomer in pure form for analysis.
(1Rʹ,2Sʹ)-1,2,4-Tribromo-1-(4-chlorophenyl)-6,6,6-trifluoro-5,5-dihydroxyhexan-3-one (4c). Yield 0.44 g (82%), white powder, mp 125–128 °C (toluene-hexane). After recrystallization from hexane, mp 154–155 °C (for the major diastereoisomer in pure form). IR (ATR) ν 3015, 1714, 1597, 1493, 1295, 1207, 990, 830, 715. 1H NMR (500 MHz, CDCl3) δ major diastereomer (80%): 4.38 (1H, s, OH); 4.74 (1H, s, OH); 4.95 (1H, s, 4-CHBr); 5.24 (1H, d, 3J = 11.3 Hz, 2-CHBr); 5.35 (1H, d, 3J = 11.3 Hz, 1-CHBr); 7.32–7.43 (4H, m, H Ar); minor diastereomer (20%): 3.94 (1H, s, OH); 4.58 (1H, s, OH); 4.98 (1H, s, 4-CHBr); 5.19 (1H, d, 3J = 11.3 Hz, 2-CHBr); 5.27 (1H, d, 3J = 11.3 Hz, 1-CHBr); 7.34–7.41 (4H, m, H Ar). 19F NMR (471 MHz, CDCl3) δ major diastereomer: 79.7 (s, CF3). Anal. Calcd for C12H9Br3ClF3O3: C 27.02; H 1.70. Found: C 27.32; H 1.79%.

3.4. Synthesis of Compound A’

A solution of dibromide 3i, which was prepared by reaction of enedione 2i (248 mg, 1 mmol) with Br2 (160 mg, 1 mmol) in CH2Cl2 (3.4 mL) without additional purification, and DIPEA (323 mg, 2.5 mmol) in CH2Cl2 (5 mL) was stirred at room temperature for 15 h. The reaction mixture was then quenched with aqueous HCl (10 mL, 0.5 M), the organic phase was separated, washed with water and brine, dried under Na2SO4, and evaporated. The crude product was purified by column chromatography (CH2Cl2).
5-Bromo-1,1,1-trifluoro-6-(thiophen-2-yl)hex-5-ene-2,4-dione (A’). Yield 183 mg (56%), dark yellow solid, mp 84–85 °C. IR (ATR) ν 1623, 1573, 1413. 1H NMR (500 MHz, CDCl3) enol form: δ 6.69 (1H, s, 3-CH); 7.22 (1H, dd, 3J = 4.9 Hz, 3J = 3.5 Hz, H-4 Th); 7.65 (1H, d, 3J = 3.5 Hz, H-3 Th); 7.72 (1H, d, 3J = 4.9 Hz, H-5 Th); 8.53 (1H, s, 6-CH); 14.77 (1H, s, OH). 19F NMR (471 MHz, CDCl3) δ 85.5 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 95.0 (q, 3JCF = 2.1 Hz, C-4); 112.4; 117.2 (q, 1JCF = 283.1 Hz, CF3); 127.6; 133.2; 134.1; 136.9; 137.7; 176.2 (q, 2JCF = 37.1 Hz, C-2); 182.3 (C-4). HRMS (ESI) m/z [M + H]+. Calcd for C10H7BrF3O2S: 326.9302. Found: 326.9315.

3.5. Synthesis of Pyrones 5

General procedure. A solution of Br2 (160 mg, 1.0 mmol) in the solvent (1.7 mL) was added to enedione 2 (1 mmol) in the solvent (2.7 mL) under cooling on an ice-bath (C6H6 was used for Method A, CH2Cl2 – Method B). After that, the reaction mixture was stirred at room temperature for 15 h, and then the solvent was evaporated without heating. Then acetone (4.3 mL) was added to the residue, and the solution was treated with Et3N (0.253 g, 2.5 mmol) under cooling on an ice-bath. After that, the reaction mixture was stirred at room temperature for 3 days and was diluted with H2O (15 mL). The precipitate was filtered, washed with water, and recrystallized from hexane.
2-Phenyl-6-(trifluoromethyl)-4H-pyran-4-one (5a). Method B. Yield 115 mg (48%), pale-yellow fine crystals, mp 85–86 °C. Procedure from dibromide 3a: Solutions of dibromide 3a (2.00 g, 5.0 mmol) in acetone (20 mL) was treated with Et3N (1.26 g, 12.5 mmol) under cooling on an ice bath. After that, the reaction mixture was stirred at room temperature for 3 days and diluted with H2O (75 mL). The precipitate was filtered, washed with water, and recrystallized from hexane. Yield 51% (0.60 g), pale-yellow fine crystals, mp 85–86 °C. IR (ATR) ν 3068, 1668, 1632, 1605, 1579, 1498, 1451, 1415. 1H NMR (400 MHz, CDCl3) δ 6.76 (1H, d, 4J = 2.1 Hz, CH); 6.84 (1H, d, 4J = 2.1 Hz, CH); 7.50–7.61 (3H, m, H Ph); 7.76–7.80 (m, 2H, H-2, H-6 Ph). 19F NMR (471 MHz, CDCl3) δ 90.3 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 112.3; 114.7 (q, 3JCF = 2.3 Hz, C-5); 118.5 (q, 1JCF = 274.8 Hz, CF3); 126.0 (2C Ar); 129.3 (2C Ar); 129.9; 132.2; 152.4 (q, 2JCF = 39.6 Hz, C-6); 163.9; 178.0 (CO). Anal. Calcd for C12H7F3O2: C 60.01; H 2.94. Found: C 59.63; H 2.56%.
2-(4-Fluorophenyl)-6-(trifluoromethyl)-4H-pyran-4-one (5b). Method A. Yield 0.18 g (69%), beige powder, mp 109–110 °C. IR (ATR) ν 3064, 1674, 1637, 1601, 1509, 1291, 1085, 945, 838. 1H NMR (400 MHz, CDCl3) δ 6.78 (1H, d, 4J = 2.1 Hz, CH); 6.82 (1H, d, 4J = 2.1 Hz, CH); 7.19–7.25 (2H, m, H-3, H-5 Ar); 7.76–7.85 (2H, m, H-2, H-6 Ar). 19F NMR (471 MHz, CDCl3) δ 55.8 (tt, 3JFH = 8.2 Hz, 4JFH = 5.1 Hz, F-Ar); 90.3 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 112.1 (d, 6JCF = 0.8 Hz, C-4); 114.8 (q, 3JCF = 2.6 Hz, C-5); 116.7 (d, 2JCF = 22.3 Hz, C-3, C-5 Ar); 118.3 (q, 1JCF = 273.5 Hz, CF3); 126.1 (d, 4JCF = 3.3 Hz, C-1 Ar); 128.3 (d, 3JCF = 9.0 Hz, C-2, C-6 Ar); 152.4 (q, 2JCF = 39.4 Hz, C-6); 163.0 (C-2); 164.9 (d, 1JCF = 253.2 Hz, C-4 Ar); 177.9 (CO). Anal. Calcd for C12H6F4O2·0.33H2O: C 54.57; H 2.54. Found: C 54.31; H 2.57%.
2-(4-Chlorophenyl)-6-(trifluoromethyl)-4H-pyran-4-one (5c). Method B. Yield 170 mg (62%), beige crystals, mp 135–137 °C. IR (ATR) ν 3061, 1671, 1632, 1605, 1492, 1416, 1407. 1H NMR (400 MHz, CDCl3) δ 6.76 (1H, d, 4J = 2.1 Hz, CH); 6.81 (1H, d, 4J = 2.1 Hz, CH); 7.51 (2H, d, 3J = 8.7 Hz, H Ar); 7.72 (2H, d, 3J = 8.7 Hz, H Ar). 19F NMR (376 MHz, CDCl3) δ 90.3 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 112.4 (C-3); 114.8 (q, 3JCF = 2.6 Hz, C-5); 118.4 (q, 1JCF = 273.7 Hz, CF3); 127.3 (2C Ar); 128.3 (C Ar); 129.7 (2C Ar); 138.7; 152.4 (q, 2JCF = 39.6 Hz, C-6); 162.8; 177.7 (CO). Anal. Calcd for C12H6ClF3O2: C 52.48; H 2.20. Found: C 52.47; H 2.40%.
2-(4-Bromophenyl)-6-(trifluoromethyl)-4H-pyran-4-one (5d). Method B. Yield 0.207 mg (65%), colorless powder, mp 161–163 °C. IR (ATR) ν 3059, 1668, 1654, 1645, 1627, 1600, 1590, 1488, 1414, 1402. 1H NMR (500 MHz, CDCl3) δ 6.76 (1H, d, 4J = 2.1 Hz, H-3); 6.82 (1H, d, 4J = 2.1 Hz, H-5); 7.64 (2H, d, 3J = 8.8 Hz, H Ar); 7.67 (2H, d, 3J = 8.8 Hz, H Ar). 19F NMR (471 MHz, CDCl3) δ 90.3 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 112.4 (C-3); 114.9 (q, 3JCF = 2.6 Hz, C-5); 118.4 (q, 1JCF = 273.9 Hz, CF3); 127.1 (C Ar); 127.4 (2C Ar); 128.8 (C Ar); 132.6 (2C Ar); 152.4 (q, 2JCF = 39.7 Hz, C-6); 162.9 (C-2); 177.7 (CO). Anal. Calcd for C12H6BrF3O2: C 45.17; H 1.90. Found: C 45.00; H 1.94%.
2-(p-Tolyl)-6-(trifluoromethyl)-4H-pyran-4-one (5f). Method B. Yield 71 mg (28%), colorless needles, 105–107 °C. IR (ATR) ν 1645, 1632, 1608, 1594, 1569, 1511, 1447. 1H NMR (500 MHz, CDCl3) δ 2.44 (3H, s, Me); 6.74 (1H, d, J = 2.1 Hz, H-5); 6.80 (1H, d, J = 2.1 Hz, H-3); 7.32 (2H, d, J = 8.1 Hz, H-3, H-5 Ar); 7.67 (2H, d, J = 8.1 Hz, H-2, H-6 Ar). 19F NMR (471 MHz, CDCl3) δ 90.3 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 21.5 (CH3); 111.6 (C-3); 114.6 (q, 3JCF = 2.5 Hz, C-5); 118.5 (q, 1JCF = 273.8 Hz, CF3); 125.9 (2C Ar); 127.0 (C Ar); 130.0 (2C Ar); 143.1(C Ar); 152.3 (q, 2JCF = 39.5 Hz, C-6); 164.1 (C-2); 178.0 (CO). HRMS (ESI) m/z [M + H]+. Calcd for C13H10F3O2: 255.0633. Found: 255.0625.
2-(4-Methoxyphenyl)-6-(trifluoromethyl)-4H-pyran-4-one (5g). Method A. Yield 176 mg (65%), yellow crystals, mp 106–107 °C. IR (ATR) ν 3019, 1685, 1598, 1522, 1489, 1432. 1H NMR (500 MHz, CDCl3) δ 3.89 (3H, s, Me); 6.73 (1H, d, 4J = 2.1 Hz, CH); 6.75 (1H, d, 4J = 2.1 Hz, CH); 7.02 (2H, d, 3J = 8.9 Hz, H-3, H-5 Ar); 7.73 (2H, d, 3J = 8.9 Hz, H-2, H-6 Ar). 19F NMR (376 MHz, CDCl3) δ 90.3 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 55.5 (CH3); 110.7 (C-3); 114.6 (q, 3JCF = 2.5 Hz, C-5); 114.7 (2C Ar); 118.6 (q, 1JCF = 273.6 Hz, CF3); 122.1 (C Ar); 127.8 (2C Ar); 152.1 (q, 2JCF = 39.4 Hz, C-6); 162.9; 164.0; 178.0 (CO). Anal. Calcd for C13H9F3O3: C 57.79; H 3.36. Found: C 57.39; H 3.39%.
2-(Thiophen-2-yl)-6-(trifluoromethyl)-4H-pyran-4-one (5i). Method A. Yield 153 mg (62%), yellow crystals, mp 87–88 °C. IR (ATR) ν 3042, 1668, 1652, 1630, 1594, 1427, 1408. 1H NMR (400 MHz, CDCl3) δ 6.68 (1H, d, J = 2.1 Hz, H-5); 6.71 (1H, d, J = 2.1 Hz, H-3); 7.19 (1H, dd, 3J = 4.9 Hz, 3J = 3.9 Hz, H-4 Th); 7.60 (1H, d, 3J = 4.9 Hz, H-5 Th); 7.65 (1H, d, 3J = 3.9 Hz, H-3 Th). 19F NMR (376 MHz, CDCl3) δ 90.3 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 110.7 (C-3); 114.8 (q, 3JCF = 2.4 Hz, C-5); 118.4 (q, 1JCF = 274.2 Hz, CF3); 128.7 (C Ar); 129.1 (C Ar); 130.9 (C Ar); 132.9 (C Ar); 151.9 (q, 2JCF = 39.7 Hz, C-6); 159.5; 177.4 (CO). HRMS (ESI) m/z [M + H]+. Calcd for C10H6F3O2S: 247.0041. Found: 247.0031.
2-(Difluoromethyl)-6-phenyl-4H-pyran-4-one (5j). Yield 40% (89 mg), yellow powder, mp 135–136 °C. IR (ATR) ν 1665, 1616, 1596, 1497, 1358, 1177, 1108, 1055, 925. 1H NMR (500 MHz, CDCl3) δ 6.47 (1H, t, 2J = 53.7 Hz, CHF2); 6.63 (1H, d, 4J = 2.2 Hz, H-3); 6.84 (1H, d, 4J = 2.2 Hz, H-5); 7.49–7.58 (3H, m, H Ph); 7.78 (2H, dd, 3J = 8.1 Hz, 4J = 1.1 Hz, H-2, H-6 Ph). 19F NMR (471 MHz, CDCl3) δ 38.3 (d, 2J = 53.7 Hz, CF2H). 13C NMR (126 MHz, CDCl3) δ 109.0 (t, 1JCF = 242.9 Hz, CF2H); 112.2; 114.4 (t, 3JCF = 4.0 Hz, C-3); 126.0 (2C Ar); 129.2 (2C Ar); 130.3; 132.0; 157.0 (t, 2JCF = 27.2 Hz, C-2); 163.9; 178.6 (CO). HRMS (ESI) m/z [M + H]+. Calcd for C12H9F2O2: 223.0571. Found: 223.0574.
2-Phenyl-6-(1,1,2,2-tetrafluoroethyl)-4H-pyran-4-one (5k). Yield 44% (120 mg), yellow powder, mp 125–126 °C. IR (ATR) ν 3074, 2924, 1663, 1622, 1452, 1239, 1104, 940. 1H NMR (500 MHz, CDCl3) δ 6.10 (1H, tt, 2J = 53.1 Hz, 3J = 2.7 Hz, CHF2); 6.77 (1H, d, 4J = 1.8 Hz, CH); 6.84 (1H, d, 4J = 1.8 Hz, CH); 7.50–7.60 (3H, m, H Ph); 7.76 (2H, dd, 3J = 7.8 Hz, 4J = 1.4 Hz, H-2, H-6 Ph). 19F NMR (471 MHz, CDCl3) δ 26.9 (dt, 2JHF = 53.0 Hz, 3JFF = 4.0 Hz, CF2); 41.1 (td, 3JFF = 4.0 Hz, 3JHF = 2.7 Hz, CF2H). HRMS (ESI) m/z [M + H]+. Calcd for C13H9F4O2: 273.0539. Found: 273.0542.
2-(1,1,2,2,3,3,4,4-Octafluorobutyl)-6-phenyl-4H-pyran-4-one (5l). Yield 70% (261 mg), pale-yellow semi-solid liquid. IR (ATR) ν 3047, 1660, 1629, 1602, 1497, 1404, 1118, 944, 767. 1H NMR (500 MHz, CDCl3) δ 6.08 (1H, tt, 2J = 51.8 Hz, 3J = 5.1 Hz, CHF2); 6.83 (1H, d, 4J = 2.0 Hz, CH); 6.88 (1H, d, 4J = 2.0 Hz, CH); 7.51 (2H, dd, 3J = 7.9 Hz, 3J = 7.3 Hz, H-3, H-5 Ph); 7.57 (1H, tt, 3J = 7.3 Hz, 4J = 1.3 Hz, H-4 Ph); 7.75 (2H, dd, 3J = 7.9 Hz, 4J = 1.3 Hz, H-2, H-6 Ph). 19F NMR (376 MHz, CDCl3) δ 24.8 (dm, 2JHF = 51.8 Hz, CF2H); 32.5–32.7 (m, 3-CF2); 37.75–37.85 (m, 2-CF2); 43.8 (tt, 3JFF = 11.4 Hz, 3JFF = 1.7 Hz, 1-CF2). HRMS (ESI) m/z [M + H]+. Calcd for C15H9F8O2: 373.0475. Found: 373.0479.

3.6. Synthesis of Pyrones 6

General procedure (Method C). A solution of Br2 (400 mg, 2.5 mmol) in CH2Cl2 (4.25 mL) was added to enedione 2 (1 mmol) in CH2Cl2 (2.7 mL) under cooling on an ice-bath. After that, the reaction mixture was stirred at room temperature for 15 h, and then the solvent was evaporated without heating. The residue was refluxed in pyridine (3 mL) at 100 °C for 10 h. The excess of pyridine was evaporated under reduced pressure and the product was purified by flash-chromatography (EtOAc). The product was hot-extracted with hexane (3 × 5 mL). The solvent was evaporated until 2 mL of hexane, and the product crystallized from the extract after cooling.
3-Bromo-6-phenyl-2-(trifluoromethyl)-4H-pyran-4-one (6a). Yield 73 mg (23%), beige solid, mp 132–133 °C. IR (ATR) ν 3069, 1646, 1600, 1451, 1146, 973, 769. 1H NMR (500 MHz, CDCl3) δ 6.94 (1H, s, H-5); 7.50–7.57 (2H, m, H-3, H-5 Ph); 7.57–7.62 (1H, m, H-4 Ph); 7.79 (2H, d, 3J = 7.4 Hz, H-2, H-6 Ph). 19F NMR (471 MHz, CDCl3) δ 95.6 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 109.3; 116.3; 118.8 (q, 1JCF = 276.4 Hz, CF3); 126.0 (2C Ph); 129.3; 129.4 (2C Ph); 132.6; 149.7 (q, 2JCF = 38.0 Hz, C-6); 163.2; 172.8 (CO). Anal. Calcd for C12H6BrF3O2: C 45.17; H 1.90. Found: C 45.36; H 1.86%.
3-Bromo-6-(4-fluorophenyl)-2-(trifluoromethyl)-4H-pyran-4-one (6b). Yield 94 mg (28%), beige solid, mp 156–167 °C. IR (ATR) ν 1667, 1627, 1556, 1412. 1H NMR (500 MHz, CDCl3) δ 6.88 (1H, s, H-5); 7.20–7.28 (2H, m, H-3, H-5 Ar); 7.77–7.85 (2H, m, H-2, H-6 Ar). 19F NMR (471 MHz, CDCl3) δ 56.4 (tt, 3JFH = 8.2 Hz, 4JFH = 5.2 Hz, F-Ar); 95.6 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 109.1 (d, 6JCF = 1.1 Hz, H-5); 116.4 (q, 3JCF = 1.1 Hz, C-3); 116.8 (d, 2JCF = 22.3 Hz, C-3, C-5 Ar); 118.7 (q, 1JCF = 276.6 Hz, CF3); 125.5 (d, 4JCF = 3.4 Hz, C-1 Ar); 128.4 (d, 3JCF = 9.1 Hz, C-2, C-6 Ar); 149.6 (q, 2JCF = 39.6 Hz, C-2); 162.2; 162.3 (d, 1JCF = 255.4 Hz, C-4 Ar); 172.7 (CO). Anal. Calcd for C12H5BrF4O2: C 42.76; H 1.50. Found: C 42.39; H 1.33%.
3-Bromo-6-(4-chlorophenyl)-2-(trifluoromethyl)-4H-pyran-4-one (6c). Yield 120 mg (34%), beige solid, mp 149–150 °C. Procedure from tribromide 3c: Tribromide 3c (533 mg, 1.0 mmol) was refluxed in pyridine (3 mL) at 100 °C for 10 h. The excess of pyridine was evaporated under reduced pressure, and the product purified by flash-chromatography (EtOAc). The product was hot-extracted with hexane (3×5 mL). The solvent was evaporated until 2 mL of hexane, and the product crystallized from extract after cooling. Yield 36% (127 mg), beige solid, mp 149–150 °C. IR (ATR) ν 3069, 1645, 1600, 1577, 1561, 1498, 1451. 1H NMR (400 MHz, CDCl3) δ 6.91 (1H, s, H-5); 7.52 (2H, d, 3J = 8.7 Hz, H Ar); 7.72 (2H, d, 3J = 8.7 Hz, H Ar). 19F NMR (376 MHz, CDCl3) δ 95.6 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 109.4 (C-5); 116.5 (C-3); 118.7 (q, 1JCF = 276.5 Hz, CF3); 127.3 (2C Ar); 127.7 (C Ar); 129.8 (2C Ar); 139.1; 149.7 (q, 2JCF = 38.1 Hz, C-2); 162.1; 172.7 (CO). HRMS (ESI) m/z [M + H]+. Calcd for C12H6BrClF3O2: 352.9186. Found: 352.9183.
3-Bromo-6-(3-nitrophenyl)-2-(trifluoromethyl)-4H-pyran-4-one (6e). Yield 15 mg (4%), yellowish solid, mp 122–125 °C. IR (ATR) ν 3074, 3055, 1672, 1647, 1615, 1596, 1532, 1442. 1H NMR (500 MHz, DMSO-d6) δ 7.58 (1H, s, H-5); 7.90 (1H, t, 3J = 8.1 Hz, H-5 Ar); 8.39 (1H, ddd, 3J = 7.9 Hz, 4J = 1.7 Hz, 4J = 0.9 Hz, H-6 Ar); 8.46 (1H, ddd, 3J = 8.2 Hz, 4J = 2.2 Hz, 4J = 0.8 Hz, H-4 Ar); 8.68 (1H, dd, 4J = 2.2 Hz, 4J = 1.7 Hz, H-2 Ar). 1H NMR (400 MHz, CDCl3) δ 7.04 (1H, s, H-5); 7.78 (1H, t, 3J = 8.8 Hz, H-5 Ar); 8.12 (1H, ddd, 3J = 7.9 Hz, 4J = 1.7 Hz, 4J = 1.0 Hz, H-6 Ar); 8.45 (1H, ddd, 3J = 8.3 Hz, 4J = 2.2 Hz, 4J = 1.0 Hz, H-4 Ar); 8.64 (1H, dd, 4J = 2.2 Hz, 4J = 1.7 Hz, H-2 Ar). 19F NMR (376 MHz, CDCl3) δ 95.6 (s, CF3). 13C NMR (126 MHz, DMSO-d6) δ 110.9; 115.8; 118.6 (q, 1JCF = 277.0 Hz, CF3); 120.8; 126.5; 131.0; 131.2; 132.4; 148.3; 148.9 (q, 2JCF = 36.8 Hz, C-2); 160.2; 172.5 (CO). HRMS (ESI) m/z [M + H]+. Calcd for C12H6BrF3NO4: 363.9427. Found: 363.9429.
3-Bromo-6-(p-tolyl)-2-(trifluoromethyl)-4H-pyran-4-one (6f). Yield 107 mg (32%), beige solid, mp 170–171 °C. IR (ATR) ν 1644, 1608, 1595, 1569, 1511, 1449. 1H NMR (500 MHz, CDCl3) δ 2.44 (3H, s, Me); 6.90 (1H, s, H-5); 7.33 (2H, d, J = 8.1 Hz, H-3, H-5 Ar); 7.67 (2H, d, J = 8.1 Hz, H-2, H-6 Ar). 19F NMR (471 MHz, CDCl3) δ 95.6 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 21.5 (CH3); 111.6 (C-3); 114.6 (q, 3JCF = 2.5 Hz, C-5); 118.5 (q, 1JCF = 273.8 Hz, CF3); 125.9 (2C Ar); 127.0 (C Ar); 130.0 (2C Ar); 143.1(C Ar); 152.3 (q, 2JCF = 39.5 Hz, C-6); 164.1 (C-2); 178.0 (CO). HRMS (ESI) m/z [M + H]+. Calcd for C13H9BrF3O2: 332.9733. Found: 332.9737.
3-Bromo-2-(difluoromethyl)-6-phenyl-4H-pyran-4-one (6j). Yield 84 mg (28%), beige solid, mp 122–123 °C. 1H NMR (500 MHz, CDCl3) δ 6.93 (1H, s, H-5); 7.00 (1H, t, 2JHF = 52.1 Hz, CHF2); 7.50–7.61 (3H, m, H Ph); 7.80–7.84 (2H, m, H-2, H-6 Ph). 19F NMR (376 MHz, CDCl3) δ 39.3 (d, 2JHF = 52.1 Hz, CF2H). 13C NMR (126 MHz, CDCl3) δ 109.3 (t, 1JCF = 242.3 Hz, CF2H); 109.5; 116.5 (t, 3JCF = 5.3 Hz, C-3); 126.1 (2C Ph); 129.3 (2C Ph); 129.6; 132.4; 152.9 (t, 2JCF = 23.9 Hz, C-2); 163.6; 172.9 (CO). HRMS (ESI) m/z [M + H]+. Calcd for C13H10F3O2: 255.0633. Found: 255.0629.
3-Bromo-6-phenyl-2-(1,1,2,2-tetrafluoroethyl)-4H-pyran-4-one (6k). Yield 77 mg (24%), beige solid, mp 122–125 °C. IR (ATR) ν 3074, 3002, 1642, 1452, 1383, 1231, 1213, 1083, 975, 842. 1H NMR (500 MHz, CDCl3) δ 6.32 (1H, tt, 2JHF = 52.8 Hz, J = 4.0 Hz, CHF2); 6.95 (1H, s, H-5); 7.51–7.56 (2H, m, H-3, H-5 Ph); 7.57–7.61 (1H, m, H-4 Ph); 7.75–7.79 (2H, m, H-2, H-6 Ph). 19F NMR (471 MHz, CDCl3) δ 26.3 (dt, 3JFF = 6.6 Hz, 3JHF = 4.1 Hz, CF2); 44.6 (td, 2JFF = 52.8 Hz, 3JFF = 6.6 Hz, CF2H). 13C NMR (126 MHz, CDCl3) δ 108.9 (tt, 1JCF = 254.1 Hz, 2JCF = 35.8 Hz, CF2H); 109.2; 111.4 (tt, 1JCF = 256.9 Hz, 2JCF = 28.9 Hz, CF2); 117.6; 126.0 (2C Ph); 129.4 (2C Ph); 130.5; 132.5; 150.9 (t, 2JCF = 27.4 Hz, C-2); 163.6; 172.8 (CO). HRMS (ESI) m/z [M + H]+. Calcd for C13H7BrF4O2: 350.9644. Found: 350.9650.
3-Bromo-2-(1,1,2,2,3,3,4,4-octafluorobutyl)-6-phenyl-4H-pyran-4-one (6l). Yield 149 mg (33%), beige solid, mp 86–88 °C. IR (ATR) ν 3075, 1640, 1499, 1453, 1377, 1145, 943. 1H NMR (400 MHz, CDCl3) δ 6.12 (3H, tt, 2JHF = 51.9 Hz, 3JHF = 5.2 Hz, CHF2); 6.95 (1H, s, H-5); 7.51–7.62 (3H, m, H Ph); 7.74–7.78 (2H, m, H-2, H-6 Ph). 19F NMR (376 MHz, CDCl3) δ 24.9 (dm, 2JHF = 51.9 Hz, CF2H); 32.4 –32.6 (m, 3-CF2); 38.7–38.8 (m, 2-CF2); 49.3 (t, 3JFF = 11.6 Hz, 1-CF2). HRMS (ESI) m/z [M + H]+. Calcd for C15H7BrF8O2: 450.9580. Found: 450.9590.

3.7. Synthesis of Fluorinated Azaheterocycles 7–9

2-Phenyl-6-(trifluoromethyl)pyridin-4(1H)-one (7). A solution of pyrone 5a (120 mg, 0.5 mmol) in EtOH (2 mL), saturated with NH3 at room temperature, was heated in an autoclave at 100 °C for 8 h. The reaction mixture was diluted with H2O (10 mL), and the formed precipitate was filtered and recrystallized from EtOH. Yield 84 mg (70%), colorless crystals, mp 133–134 °C. IR (ATR) ν 1614, 1579, 1481, 1427, 1460, 1429. 1H NMR (400 MHz, DMSO-d6) δ pyridinol form (96%): 7.05 (1H, s, H-3); 7.25 (1H, s, H-5); 7.39–7.48 (3H, m, H Ph); 7.91 (2H, d, J = 6.8 Hz, H-2, H-6 Ph); pyridone form (4%): 6.87 (1H, d, 4J = 2.0 Hz, H-3); 6.84 (1H, d, 4J = 2.0 Hz, H-5); 7.39–7.48 (3H, m, H Ph); 7.87–7.94 (2H, m, H-2, H-6 Ph); the signals from NH and OH were not observed due to the fast exchange with water. 19F NMR (376 MHz, CDCl3) δ pyridone form (4%): 93.4 (s, CF3); pyridinol form (96%): 93.6 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 108.3 Hz, 111.2 Hz, 121.2 (q, 1JCF = 274.4 Hz, CF3); 127.1 (2C Ph); 128.9 (2C Ph); 130.0 Hz, 137.2 Hz, 148.1 Hz, 158.9 Hz, 166.5. Anal. Calcd for C12H8F3NO: C 60.26; H 3.37; N 5.86. Found: C 60.35; H 3.26; N 5.84%.
1-Phenyl-3-(4-(trifluoromethyl)-1H-1,2,3-triazol-5-yl)propane-1,3-dione (8). To a solution of pyrone 5a (96 mg, 0.4 mmol) in DMSO (1 mL), NaN3 (29 mg, 0.44 mmol) was added, and the mixture was stirred at 115–120 °C for 30 min. The reaction was then diluted with aqueous HCl (10 mL, 0.1 M), and the formed precipitate was filtered and recrystallized from toluene. Yield 65 mg (55%), pale-brown plates, mp 189–190 °C. IR (ATR) ν 3268 (NH), 1600, 1575, 1535, 1492, 1460, 1429. 1H NMR (400 MHz, DMSO-d6) δ enol form (82%): 7.19 (1H, s, 2-CH); 7.59 (2H, t, J = 7.6 Hz, H-3, H-5 Ph); 7.68 (1H, t, J = 7.4 Hz, H-4 Ph); 8.05 (2H, d, J = 7.4 Hz, H-2, H-6 Ph); 14.70–17.9 (2H, broad s, NH, OH); keto form (18%): 4.85 (2H, s, CH2); 7.58 (2H, t, J = 7.4 Hz, H-3, H-5 Ph); 7.70 (1H, t, J = 7.4 Hz, H-4 Ph); 8.01 (2H, d, J = 7.4 Hz, H-2, H-6 Ph); 14.70–17.9 (1H, broad s, NH). 19F NMR (376 MHz, DMSO-d6) δ keto form (18%): 102.2 (s, CF3); enol form (82%): 103.2 (s, CF3). 13C NMR (126 MHz, DMSO-d6) δ enol form: 94.9 (CH=); 120.7 (q, 1JCF = 268.5 Hz, CF3); 127.2 (2C Ar); 129.1 (2C Ar); 133.2 (C Ar); 133.2 (C Ar); 136.2 (q, 2JCF = 40.1 Hz, C-CF3); 140.9 (C Ar); 179.6; 182.2; keto form: 50.7 (CH2); 120.2 (q, 1JCF = 267.1 Hz, CF3); 128.5 (2C Ar); 128.9 (2C Ar); 133.9 (C Ar); 136.0 (C Ar); 136.2 (q, 2JCF = 40.5 Hz, C-CF3); 142.4 (C Ar); 187.9 (CO); 194.8 (CO). Anal. Calcd for C12H8F3N3O2: C 50.89; H 2.85; N 14.84. Found: C 50.90; H 2.78; N 14.85%.
(E)-1,5-Diphenyl-3-(3,3,3-trifluoro-2-(2-phenylhydrazono)propyl)-1H-pyrazole (9). A mixture of pyrone 5a (120 mg, 0.5 mmol) and phenylhydrazine (270 mg, 2.5 mmol) was heated at 120 °C for 3 h. The reaction mixture was cooled to room temperature, treated with 1M HCl solution (10 mL), the formed precipitate was filtered and recrystallized from EtOH. Yield 65 mg (55%), colorless crystals, mp 171–173 °C. IR (ATR) ν 3267 (NH), 1605 (C=N), 1543, 1500, 1457. 1H NMR (500 MHz, CDCl3) δ 3.84 (2H, s, H-3); 6.40 (1H, s, H-5); 6.91 (1H, t, J = 7.3 Hz, H-4 Ph); 7.11 (2H, d, J = 7.8 Hz, H-2, H-6 Ph); 7.19 (2H, dd, 3J = 7.7 Hz, 4J = 1.5 Hz, H-2, H-6 Ph); 7.22–7.38 (3H, m, H Ph); 9.99 (1H, s, NH). 19F NMR (376 MHz, CDCl3) δ 92.8 (s, CF3). 13C NMR (126 MHz, CDCl3) δ 24.6; 107.2; 113.5 (2C); 121.4; 121.94 (q, 1JCF = 272.0 Hz, CF3); 125.1 (2C); 127.8; 128.5 (2C); 128.6; 128.7 (2C); 128.78 (q, 2JCF = 33.9 Hz, C=N); 129.0 (2C); 129.2 (2C); 129.8; 139.6; 144.1; 144.8; 147.1. Anal. Calcd for C24H19F3N4: C 68.56; H 4.56; N 13.33. Found: C 68.42; H 4.38; N 13.34%.

Supplementary Materials

The following are available online, Scheme S1. Reaction of (3Z,5E)-6-(4-(dimethylamino)phenyl)-1,1,1-trifluoro-4-hydroxyhexa-3,5-dien-2-one with Br2 in benzene; Table S1. Composition of reaction mixtures of bromination of enediones 2; Table S2. Characteristic chemical shifts in 1H and 19F NMR spectra of compounds 3; Table S3. Characteristic chemical shifts in 1H and 19F NMR spectra of compounds 4; Table S4. Characteristic chemical shifts in 1H and 19F NMR spectra of dihydropyrone forms of 3; Table S5. Characteristic chemical shifts in 1H and 19F NMR spectra of dihydropyrone forms of 4; full 1H, 19F, and 13C NMR spectra of all synthesized compounds.

Author Contributions

Conceptualization and methodology were provided by V.Y.S., S.A.U. and D.L.O. conceived and designed the experiments. The experimental work was conducted by D.I.N., D.K.M., N.A.N., and S.A.U. S.A.U. and D.L.O. analyzed the results. S.A.U. studied and systemized the NMR data. V.Y.S. and D.L.O. wrote the paper. Project administration and funding acquisition were carried out by V.Y.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Russian Science Foundation, grant number 18-13-00186.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article and Supplementary Materials.

Acknowledgments

Analytical studies were carried out using equipment at the Center for Joint Use ‘Spectroscopy and Analysis of Organic Compounds’ at the Postovsky Institute of Organic Synthesis of the Russian Academy of Sciences (Ural Branch) and the Laboratory of Complex Investigations and Expert Evaluation of Organic Materials of the Center for Joint Use at the Ural Federal University. Authors would like to thank Artem Chudinov for his help in the work.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are not available from the authors.

References

  1. Singh, K.S. Pyrone-derived marine natural products: A review on isolation, bio-activities and synthesis. Curr. Org. Chem. 2020, 24, 354–401. [Google Scholar] [CrossRef]
  2. Rukachaisirikul, V.; Kannai, S.; Klaiklay, S.; Phongpaichit, S.; Sakayaroj, J. Rare 2-phenylpyran-4-ones from the seagrass-derived fungi Polyporales PSU-ES44 and PSU-ES83. Tetrahedron 2013, 69, 6981–6986. [Google Scholar] [CrossRef]
  3. Zhang, Y.; Zhu, T.; Fang, Y.; Liu, H.; Gu, Q.; Zhu, W. Carbonarones A and B, new bioactive γ-pyrone and α-pyridone derivatives from the marine-derived fungus Aspergillus carbonarius. J. Antibiot. 2007, 60, 153–157. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Ola, A.R.B.; Thomy, D.; Lai, D.; BroJz-Oesterhelt, H.; Proksch, P. Inducing secondary metabolite production by the endophytic Fungus Fusarium tricinctum through coculture with Bacillus subtilis. J. Nat. Prod. 2013, 76, 2094–2099. [Google Scholar] [CrossRef] [PubMed]
  5. Kunze, B.; Jansen, R.; Pridzun, L.; Jurkiewicz, E.; Hunsmann, G.; Höfle, G.; Reichenbach, H. Phenoxan, a new oxazole-pyrone from myxobacteria: Production, antimicrobial activity and its inhibition of the electron transport in complex I of the respiratory chain. J. Antibiot. 1992, 45, 1549–1552. [Google Scholar] [CrossRef] [Green Version]
  6. Bejcek, L.P.; Murelli, R.P. Oxidopyrylium [5 + 2] cycloaddition chemistry: Historical perspective and recent advances (2008–2018). Tetrahedron 2018, 74, 2501–2521. [Google Scholar] [CrossRef]
  7. Zirak, M.; Eftekhari-Sis, B. Kojic acid in organic synthesis. Turk. J. Chem. 2015, 39, 439–496. [Google Scholar] [CrossRef]
  8. Zhang, L.; Cao, T.; Jiang, H.; Zhu, S. Deconstructive reorganization: De Novo synthesis of hydroxylated benzofuran. Angew. Chem. Int. Ed. 2020, 59, 4670–4677. [Google Scholar] [CrossRef]
  9. Obydennov, D.L.; Khammatova, L.R.; Steben’kov, V.D.; Sosnovskikh, V.Y. Synthesis of novel polycarbonyl Schiff bases by ring-opening reaction of ethyl 5-acyl-4-pyrone-2-carboxylates with primary mono- and diamines. RSC Adv. 2019, 9, 40072–40083. [Google Scholar] [CrossRef] [Green Version]
  10. Schreiner, E.; Richter, F.; Nerdinger, S. Development of synthetic routes to dolutegravir. Top. Heterocycl. Chem. 2016, 44, 187–208. [Google Scholar]
  11. Guo, Z.; Zhu, W.; Tian, H. Dicyanomethylene-4H-pyranchromophores for OLED emitters, logic gates and optical chemosensors. Chem. Commun. 2012, 48, 6073–6084. [Google Scholar] [CrossRef] [PubMed]
  12. Obydennov, D.L.; Suslova, A.I.; Sosnovskikh, V.Y. Synthesis and some chemical properties of 2-cyano-4-pyrone. Chem. Heterocycl. Compd. 2020, 56, 173–179. [Google Scholar] [CrossRef]
  13. Obydennov, D.L.; Simbirtseva, A.E.; Piksin, S.E.; Sosnovskikh, V.Y. 2,6-Dicyano-4-pyrone as a novel and multifarious building block for the synthesis of 2,6-bis(hetaryl)-4-pyrones and 2,6-bis(hetaryl)-4-pyridinols. ACS Omega 2020, 5, 33406–33420. [Google Scholar] [CrossRef]
  14. Obydennov, D.L.; Sosnovskikh, V.Y. The reaction of 6-substituted 4-pyrone-2-carboxylic acids with o-phenylenediamine. Synthesis and structure of 3-(1H-1,5-benzodiazepin-2(3H)-ylidenemethyl)quinoxalin-2(1H)-ones. Chem. Heterocycl. Compd. 2015, 51, 281–290. [Google Scholar] [CrossRef]
  15. Obydennov, D.L.; Khammatova, L.R.; Eltsov, O.S.; Sosnovskikh, V.Y. A chemo- and regiocontrolled approach to bipyrazoles and pyridones via the reaction of ethyl 5-acyl-4-pyrone-2-carboxylates with hydrazines. Org. Biomol. Chem. 2018, 16, 1692–1707. [Google Scholar] [CrossRef]
  16. Obydennov, D.L.; Usachev, B.I.; Sosnovskikh, V.Y. Reactions of 2-mono- and 2,6-disubstituted 4-pyrones with phenylhydrazine as general method for the synthesis of 3-(N-phenylpyrazolyl)indoles. Chem. Heterocycl. Compd. 2015, 50, 1388–1403. [Google Scholar] [CrossRef]
  17. Politanskaya, L.; Selivanova, G.A.; Panteleeva, E.V.; Tretyakov, E.V.; Platonov, V.E.; Nikul’Shin, P.V.; Vinogradov, A.S.; Zonov, Y.V.; Karpov, V.M.; Mezhenkova, T.V.; et al. Organofluorine chemistry: Promising growth areas and challenges. Russ. Chem. Rev. 2019, 88, 425–569. [Google Scholar] [CrossRef]
  18. Usachev, B.I. 2-(Trifluoromethyl)-4H-pyran-4-ones: Convenient, available and versatile building-blocks for regioselective syntheses of trifluoromethylated organic compounds. J. Fluor. Chem. 2015, 172, 80–91. [Google Scholar] [CrossRef]
  19. Usachev, S.A.; Sosnovskikh, V.Y. Synthesis of γ-pyrone precursors by condensation of acetyl ketene dithioacetals with ethyl polyfluorocarboxylates and diethyl oxalate. Chem. Heterocycl. Compd. 2016, 52, 1005–1011. [Google Scholar] [CrossRef]
  20. Yeates, C.L.; Batchelor, J.F.; Capon, E.C.; Cheesman, N.J.; Fry, M.; Hudson, A.T.; Pudney, M.; Trimming, H.; Woolven, J.; Bueno, J.M.; et al. Synthesis and structure–activity relationships of 4-pyridones as potential antimalarials. J. Med. Chem. 2008, 51, 2845–2852. [Google Scholar] [CrossRef] [PubMed]
  21. Tyvorskii, V.I.; Bobrov, D.N.; Kulinkovich, O.G.; Aelterman, W.; de Kimpe, N. Synthesis of 3-(trifluoromethyl)benzo[c][1,6]naphthyridines from substituted 4H-pyran-4-ones via 4-amino-5-aryl-2-(trifluoromethyl)pyridines. Tetrahedron 2000, 56, 7313–7318. [Google Scholar] [CrossRef]
  22. Büttner, S.; Desens, W.; Michalik, D.; Langer, P. Synthesis and structures of fluoroalkylated triketides. Eur. J. Org. Chem. 2011, 6663–6669. [Google Scholar] [CrossRef]
  23. Serdyuk, R.N.; Sizov, A.Y.; Ermolov, A.F. Polyfluoroalkylthiotrifluoroacetylketenes. Rus. Chem. Bull. 2003, 52, 1854–1858. [Google Scholar] [CrossRef]
  24. Boivin, J.; El Kaima, L.; Zarda, S.Z. Trifluoromethyl ketones from carboxylic acids. Part II. A versatile access to trifluoromethylated heterocycles. Tetrahedron 1995, 51, 2585–2592. [Google Scholar] [CrossRef]
  25. Krasnykh, O.P.; Aleksandrov, G.G.; Karpenko, N.S.; Filyakova, V.I.; Charushin, V.N. Formation of fluoroalkyl-containing pyran-4-one in the reaction of lithium 4,4,4-trifluoro-1-phenylbutane-1,3-dionate with oxalyl chloride. Rus. Chem. Bull. 2007, 56, 178–180. [Google Scholar] [CrossRef]
  26. Usachev, B.I.; Obydennov, D.L.; Rӧschenthaler, G.-V.; Sosnovskikh, V.Y. 2-Cyano-6-(trifluoromethyl)-4-pyran-4-one: A novel versatile CF3-containing building block. J. Fluor. Chem. 2012, 137, 22–26. [Google Scholar] [CrossRef]
  27. Sosnovskikh, V.Y. Synthesis and reactions of halogen-containing chromones. Russ. Chem. Rev. 2003, 72, 489–516. [Google Scholar] [CrossRef]
  28. Sosnovskikh, V.Y.; Korotaev, V.Y.; Chizhov, D.L.; Kutyashev, I.B.; Yachevskii, D.S.; Kazheva, O.N.; Dyachenko, O.A.; Charushin, V.N. Reaction of polyhaloalkyl-substituted chromones, pyrones, and furanones with salicylaldehydes as a direct route to fused 2H-chromenes. J. Org. Chem. 2006, 71, 4538–4543. [Google Scholar] [CrossRef] [PubMed]
  29. Liu, W.; Fang, L.; Wan, Y.; Zhang, J.; Deng, G.; Wang, J. Synthesis of 2-cyclopropyl-4-pyrones and 5-cyclopropyl-2-alkylene-3(2H)-furanones based on tandem cyclization-cyclopropanation strategy. Tetrahedron 2019, 75, 855–861. [Google Scholar] [CrossRef]
  30. Wang, F.; Lu, S.; Chen, B.; Zhou, Y.; Yang, Y.; Deng, G. Regioselective reversal in the cyclization of 2-diazo-3,5-dioxo-6-ynoates (ynones, ynamide): Construction of γ-pyrones and 3(2H)-furanones starting from identical materials. Org. Lett. 2016, 18, 6248–6251. [Google Scholar] [CrossRef] [PubMed]
  31. Solas, M.; Muñoz, M.A.; Suárez-Pantiga, S.; Sanz, R. Regiodivergent hydration−cyclization of diynones under gold catalysis. Org. Lett. 2020, 22, 7681–7687. [Google Scholar] [CrossRef]
  32. Fürstner, A. Gold catalysis for heterocyclic chemistry: A representative case study on pyrone natural products. Angew. Chem. Int. Ed. 2018, 57, 4215–4233. [Google Scholar] [CrossRef]
  33. Zhang, J.; Deng, G.; Wang, J. Diastereoselective synthesis of 2-(1,3-dioxolanes-4-yl)-4H-pyran-4-ones from 2-diazo-3,5-dioxo-6-ynoates (sulfones) and aldehydes based on tandem cyclization-cycloaddition strategy. Eur. J. Org. Chem. 2019, 2019, 3979–3986. [Google Scholar] [CrossRef]
  34. Usachev, B.I.; Obydennov, D.L.; Kodess, M.I.; Röschenthaler, G.-V.; Sosnovskikh, V.Y. New derivatives of 6-phenylcomanic acid. Rus. Chem. Bull. 2009, 58, 1248–1252. [Google Scholar] [CrossRef]
  35. Soliman, G.; Rateb, L. Synthesis of heterocyclic compounds from δ-unsaturated 1:3-diketo-esters. J. Chem. Soc. 1956, 3663–3668. [Google Scholar] [CrossRef]
  36. Clark, B.P.; Ross, W.J.; Todd, A. 6-Substituted Pyranone Compounds and Their Use as Pharmaceuticals. US Patent 4471129, 1984. [Google Scholar]
  37. Borsche, W.; Peter, W. Über eine neue y-Pyronsynthese. Justus Liebigs Ann. Chem. 1927, 53, 148–162. [Google Scholar] [CrossRef]
  38. Pashkevich, K.L.; Khomutov, O.G. Synthesis of polyfluoroalkyl-containing dienones. Rus. Chem. Bull. 1996, 45, 2169–2171. [Google Scholar] [CrossRef]
  39. Kim, E.; Felouat, A.; Zaborova, E.; Ribierre, J.-C.; Wu, J.W.; Senatore, S.; Matthews, C.; Lenne, P.-F.; Baffert, C.; Karapetyan, A.; et al. Borondifluoride complexes of hemicurcuminoids as bio-inspired push-pull dyes for bioimaging. Org. Biomol. Chem. 2016, 14, 1311–1324. [Google Scholar] [CrossRef]
  40. Sosnovskikh, V.Y.; Ovsyannikov, I.S. Condensation of trichloro- and trfluoroacetonitriles with mesityl oxide and arylideneacetones. Russ. J. Org. Chem. 1993, 29, 214–219. [Google Scholar]
  41. Leng, D.J.; Black, C.M.; Pattison, G. One-pot synthesis of difluoromethyl ketones by a difluorination/fragmentation process. Org. Biomol. Chem. 2016, 14, 1531–1535. [Google Scholar] [CrossRef] [Green Version]
  42. Kobelevskaya, V.A.; Popov, A.V.; Zinchenko, S.V.; Rulev, A.Y. Chemoselective bromination of dienoates. Eur. J. Org. Chem. 2020, 2020, 5544–5550. [Google Scholar] [CrossRef]
  43. Usachev, S.A.; Usachev, B.I.; Eltsov, O.S.; Sosnovskikh, V.Y. Synthesis of isomerically pure 3-(5-trifluoromethyl-1,2,3-triazol-4-yl)cinnamic acid derivatives via the reaction of 4-aryl-6-trifluoromethyl-2-pyrones with sodium azide. Tetrahedron 2014, 70, 8863–8871. [Google Scholar] [CrossRef]
  44. He, Y.-H.; He, T.; Guo, J.-T.; Li, R.; Xiang, Y.; Yang, D.-C.; Guan, Z. Enzyme-catalyzed domino reaction: Efficient construction of spirocyclic oxindole skeleton using porcine pepsin. Catal. Sci. Technol. 2016, 6, 2239–2248. [Google Scholar] [CrossRef]
Molecules 26 04415 g001 550
Figure 1. Some representative examples of biologically important arylated 4-pyrones.
Figure 1. Some representative examples of biologically important arylated 4-pyrones.
Molecules 26 04415 g001
Molecules 26 04415 sch001 550
Scheme 1. The main strategies in the synthesis of arylated 2-RF-4-pyrones [20,21,23].
Scheme 1. The main strategies in the synthesis of arylated 2-RF-4-pyrones [20,21,23].
Molecules 26 04415 sch001
Molecules 26 04415 sch002 550
Scheme 2. Synthesis of enediones 2 via Claisen condensation.
Scheme 2. Synthesis of enediones 2 via Claisen condensation.
Molecules 26 04415 sch002
Molecules 26 04415 sch003 550
Scheme 3. Reaction of enediones 2 with Br2.
Scheme 3. Reaction of enediones 2 with Br2.
Molecules 26 04415 sch003
Molecules 26 04415 sch004 550
Scheme 4. Preparative bromination of enediones 2.
Scheme 4. Preparative bromination of enediones 2.
Molecules 26 04415 sch004
Molecules 26 04415 sch005 550
Scheme 5. Cyclization of dibromo derivatives 3 to pyrones 5.
Scheme 5. Cyclization of dibromo derivatives 3 to pyrones 5.
Molecules 26 04415 sch005
Molecules 26 04415 sch006 550
Scheme 6. Cyclization of tribromo derivative 4c to pyrone 6c.
Scheme 6. Cyclization of tribromo derivative 4c to pyrone 6c.
Molecules 26 04415 sch006
Molecules 26 04415 sch007 550
Scheme 7. One-pot preparation of pyrones 5 and 6 from enediones 2.
Scheme 7. One-pot preparation of pyrones 5 and 6 from enediones 2.
Molecules 26 04415 sch007
Molecules 26 04415 sch008 550
Scheme 8. Synthesis of 2-aryl-6-polyfluoroalkyl-4-pyrones 6j–l.
Scheme 8. Synthesis of 2-aryl-6-polyfluoroalkyl-4-pyrones 6j–l.
Molecules 26 04415 sch008
Molecules 26 04415 sch009 550
Scheme 9. Reaction of pyrone 5a with N-nucleophiles for the synthesis of fluorinated azaheterocycles.
Scheme 9. Reaction of pyrone 5a with N-nucleophiles for the synthesis of fluorinated azaheterocycles.
Molecules 26 04415 sch009
Table
Table 1. The scope of prepared enediones 2.
Table 1. The scope of prepared enediones 2.
EnedioneArRFYield, %Mp, °C
2aPhCF37556–58
2b4-FC6H4CF36483–84
2c4-ClC6H4CF36092–93
2d4-BrC6H4CF39286–87
2e3-O2NC6H4CF351 a119–120
2f4-MeC6H4CF36561–62
2g4-MeOC6H4CF381104–105
2h4-Me2NC6H4CF36779–80
2i2-C4H3SCF38494–95
2jPhCF2H4385–87
2kPhH(CF2)243Liq.
2lPhH(CF2)451Liq.
a Lithium hydride in benzene under reflux.
Table
Table 2. Selectivity of bromination of enediones 2 a.
Table 2. Selectivity of bromination of enediones 2 a.
№ArEnedioneBr2
Equiv.		Solvent2:3:4 Ratio b
14-FC6H42b1.0AcOH e74:(7 + 2 c):(16 + 1 c)
24-FC6H42b1.0CH2Cl242:(37 + 2 c):19
34-FC6H42b2.5CH2Cl20:7 c:93
44-FC6H42b1.0t-BuOMe17:(31 + 4 c):(39 + 9 c)
54-FC6H42b1.0dioxane29:65:6
64-FC6H42b1.0CS225:(65 + 2 c):(7 + 1 c)
74-FC6H42b1.0C6H612:78:10
84-FC6H42b1.2C6H60:(75 + 4 c):(19 + 2 c)
94-FC6H42b2.2C6H60:(46 + 10 c):(33 + 11 c)
104-MeOC6H42g1.0C6H63:75:22
112-C4H3S2i1.0C6H69:(80 + 8 d):3
124-ClC6H42c1.0C6H662:(10 + 3 c):25
133-O2NC6H42e1.0C6H655:(14 + 2 c):(26 + 3 c)
14Ph2a1.0C6H662:24:14
15Ph2a1.0CH2Cl20:(86 + 2 c):12
a A solution of Br2 was added to enedione 2 under cooling on an ice-bath. The reaction mixture was stirred at room temperature for 15 h. b Based on the 19F and 1H NMR spectra. c Cyclized to dihydropyrone. d A product of dehydrobromination was spontaneously formed. e Br2 was added at room temperature.
Table
Table 3. The scope of 4-pyrone synthesis via the one-pot oxidative cyclization of enediones 2.
Table 3. The scope of 4-pyrone synthesis via the one-pot oxidative cyclization of enediones 2.
EnedioneArPyroneMethodYield, %
2aPh5aB48
2b4-FC6H45bA69
2c4-ClC6H45cB62
2d4-BrC6H45dB65
2f4-MeC6H45fB28
2g4-MeOC6H45gA65
2i2-C4H3S5iA62
2aPh6aC23
2b4-FC6H46bC28
2c4-ClC6H46cC34
2e3-O2NC6H46eC4
2f4-MeC6H46fC42
Method A: The mixture of enedione 2 (1.0 mmol) with bromine (1.0 mmol) in C6H6 was stirred at room temperature. Cyclization was carried out in the presence of Et3N (2.5 equiv.) in acetone. Method B: The mixture of enedione 2 (1.0 mmol) with bromine (1.0 mmol) was stirred in CH2Cl2 at room temperature. Cyclization was carried out in the presence of Et3N in acetone. Method C: The mixture of enedione 2 (1.0 mmol) with bromine (2.5 mmol) in CH2Cl2 was stirred at room temperature. Cyclization was carried in pyridine at 100 °C for 10 h.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Usachev, S.A.; Nigamatova, D.I.; Mysik, D.K.; Naumov, N.A.; Obydennov, D.L.; Sosnovskikh, V.Y. 2-Aryl-6-Polyfluoroalkyl-4-Pyrones as Promising RF-Building-Blocks: Synthesis and Application for Construction of Fluorinated Azaheterocycles. Molecules 2021, 26, 4415. https://doi.org/10.3390/molecules26154415

AMA Style

Usachev SA, Nigamatova DI, Mysik DK, Naumov NA, Obydennov DL, Sosnovskikh VY. 2-Aryl-6-Polyfluoroalkyl-4-Pyrones as Promising RF-Building-Blocks: Synthesis and Application for Construction of Fluorinated Azaheterocycles. Molecules. 2021; 26(15):4415. https://doi.org/10.3390/molecules26154415

Chicago/Turabian Style

Usachev, Sergey A., Diana I. Nigamatova, Daria K. Mysik, Nikita A. Naumov, Dmitrii L. Obydennov, and Vyacheslav Y. Sosnovskikh. 2021. "2-Aryl-6-Polyfluoroalkyl-4-Pyrones as Promising RF-Building-Blocks: Synthesis and Application for Construction of Fluorinated Azaheterocycles" Molecules 26, no. 15: 4415. https://doi.org/10.3390/molecules26154415

APA Style

Usachev, S. A., Nigamatova, D. I., Mysik, D. K., Naumov, N. A., Obydennov, D. L., & Sosnovskikh, V. Y. (2021). 2-Aryl-6-Polyfluoroalkyl-4-Pyrones as Promising RF-Building-Blocks: Synthesis and Application for Construction of Fluorinated Azaheterocycles. Molecules, 26(15), 4415. https://doi.org/10.3390/molecules26154415

Article Metrics

Back to TopTop